Tuesday, 02 January 2024 12:17 GMT

Are You Looking For Funding For Your Performing Arts Project? We Are Announcing Ibsen Scope Grants 2026.


(MENAFN- AETOSWire) (BUSINESS WIRE ) -- The Ibsen Scope Grants program offers funding for innovative performing arts projects and is now applicable for individual artists, theatre companies, institutions, and organizations worldwide.

The program amounts to a total of NOK 2.000.000,-. (Approx. Euro 180.000,- /USD 190.000,-).

The projects must act as incentives for critical discourses on society related matters and be based on one or more of Henrik Ibsen's plays.

Applications are submitted through our website, and an appointed jury will evaluate the applications.

For further information, statutes and application form, see

Deadline for applications is December 17th, 2025.

The winners of the Ibsen Scope Grants 2026 are invited to Ibsen Scope Festival at Teater Ibsen in Skien, Norway May 7th to 9th 2026.

The Ibsen Scope Grants were initiated by the Norwegian government in 2007 and will be awarded for the 14th time in 2026. Ibsen Scope Grants have now been awarded to 53 projects in 32 countries. See all winners here

Since our initial year Ibsen Scope has:

-looked at the world through Henrik Ibsen's lenses

-engaged in vivid, critical, and artistic discourses on the works and topics potentially raised from Henrik Ibsen's legacy

-offered funding for innovative theatre performances through Ibsen Scope Grants

-arranged Ibsen Scope Festival, an international theatre festival, meeting point and platform for artists

Continue to follow us on our artistic journey worldwide!

Facebook

Instagram

View source version on businesswire:


Permalink

MENAFN02102025004146001356ID1110143402



Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.